Dramatic response to pembrolizumab after pseudoprogression in a patient with advanced metastatic castration‐resistant prostate cancer

INTRODUCTION: Prostate cancer with a microsatellite instability‐high or mismatch repair‐deficient status is not common. Few reports of the response to pembrolizumab in metastatic castration‐resistant prostate cancer in a real‐world setting have been reported. This case report describes a dramatic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kageyama, Takumi, Soga, Norihito, Sekito, Sho, Kato, Seiichi, Ogura, Yuji, Kojima, Takahiro, Kanai, Masahiro, Inoue, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626308/
https://www.ncbi.nlm.nih.gov/pubmed/36341181
http://dx.doi.org/10.1002/iju5.12508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626308/
https://www.ncbi.nlm.nih.gov/pubmed/36341181
http://dx.doi.org/10.1002/iju5.12508

Ejemplares similares